miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1
Document Type: Research Article
Affiliations: 1: Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, P.R. China 2: Department of Pediatrics, The First Hospital of Jilin University, Changchun, P.R. China
Publication date: April 10, 2018
This article was made available online on June 26, 2017 as a Fast Track article with title: "MiR-205 Inhibits Growth and Invasion of Neuroblastoma by Targeting cAMP Responsive Element Binding Protein 1".
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.